Determinants, Consequences and Potential Solutions to Poor Adherence to Anti-Osteoporosis Treatment: Results of an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, [...]
- Hiligsmann, M.
- Cornelissen, D.
- Vrijens, B.
- Abrahamsen, B.
- Al-Daghri, N.
- Biver, Emmanuel
- Brandi, M.L.
- Bruyère, O.
- Burlet, N.
- Cooper, C.
- Cortet, B.
- Dennison, E.
- Diez-Perez, A.
- Gasparik, A.
- Grosso, A.
- Hadji, P.
- Halbout, P.
- Kanis, J.A.
- Kaufman, J.M.
- Laslop, A.
- Maggi, S.
- Rizzoli, René
- Thomas, T.
- Tuzun, S.
- Vlaskovska, M.
- Reginster, J.Y.
Publication date
January 2019
DOI Publisher
Springer Science and Business Media LLCAbstract
Many patients at increased risk of fractures do not take their medication appropriately, resulting in a substantial decrease in the benefits of drug therapy. Improving medication adherence is urgently needed but remains laborious, given the numerous and multidimensional reasons for non-adherence, suggesting the need for measurement-guided, multifactorial and individualized solutions
Add to ORKG